Table 2 Probability values
From: Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Health State | Probability | References |
|---|---|---|
Afirma | ||
Lobectomy | 0.389 | 11 |
Malignancy diagnosed on lobectomy | 0.440 | 11, EO |
Eventual lobectomy following observation | 0.400 | 13, EO |
Malignancy in nodules being observed | 0.091 | 11 |
Current Practice | ||
Lobectomy | 0.740 | 8 |
Malignancy diagnosed on lobectomy | 0.195 | 4, 5 |
Eventual lobectomy following observation | 0.400 | 13, EO |
Malignancy in nodules being observed | 0.160 | 11, EO |
Both | ||
Complication following lobectomy | 0.135 | 4, 5, EO |
Complication following completion thyroidectomy | 0.117 | 4, 5, EO |
Completion thyroidectomy following lobectomy for malignancy pathology | 0.042 | 12 |